IL-15-dependent balance between Foxp3 and RORγt expression impacts inflammatory bowel disease

Nature Communications

Volumn 7, Issue , 2016, Pages

  Tosiek, Milena J ^a,b   Fiette, Laurence ^c,d   El Daker, Sary ^a,b   Eberl, Gérard ^a,b   Freitas, Antonio A ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 4; INTERLEUKIN 6; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX1; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

CELLS AND CELL COMPONENTS; DISEASE INCIDENCE; HEALTH RISK; IMMUNE SYSTEM; PHENOTYPE; PROTEIN; RISK ASSESSMENT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL PLASTICITY; CELL SURVIVAL; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CONTROL; DOWN REGULATION; ENTERITIS; FEMALE; GOBLET CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY CELL; LAMINA PROPRIA; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; UPREGULATION; WEIGHT REDUCTION; ANIMAL; CELL DIFFERENTIATION; COLON; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

MUS;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COLON; CYTOKINES; DOWN-REGULATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-15; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84960935465     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10888     Document Type: Article

References (43)

1. Kaser, A., Zeissig, S. & Blumberg, R. S. Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573-621 (2010).
2. Pagliari, D. et al. The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev. 24, 455-466 (2013).
3. Liu, Z. et al. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 164, 3608-3615 (2000).
4. Perrier, C. et al. Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab. Immunology 138, 47-56 (2013).
5. Yoshihara, K., Yajima, T., Kubo, C. & Yoshikai, Y. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut. 55, 334-341 (2006).
6. Obermeier, F. et al. IL-15 protects intestinal epithelial cells. Eur. J. Immunol. 36, 2691-2699 (2006).
7. Silva, M. a, Menezes, J., Deslandres, C. & Seidman, E. G. Anti-inflammatory role of interleukin-15 in Crohn's disease. Inflamm. Bowel Dis. 11, 219-230 (2006).
8. Budagian, V., Bulanova, E., Paus, R. & Bulfone-Paus, S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17, 259-280 (2006).
9. Bulfone-Paus, S., Bulanova, E., Budagian, V. & Paus, R. The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signalling. Bioessays 28, 362-377 (2006).
10. Stonier, S. W. & Schluns, K. S. Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol. Lett. 127, 85-92 (2010).
11. Pandiyan, P. et al. The role of IL-15 in activating STAT5 and fine-tuning IL-17A production in CD4 T lymphocytes. J. Immunol. 189, 4237-4246 (2012).
12. Strober, W. & Fuss, I. J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1756-1767 (2011).
13. Kleinewietfeld, M. & Hafler, D. A. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin. Immunol. 25, 305-312 (2013).
14. Bovenschen, H. J. et al. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 131, 1853-1860 (2011).
15. - cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology 142, 1526-1535 (2012).
16. Li, L. & Boussiotis, V. A. The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer. Clin. Immunol. 148, 246-253 (2013).
17. Damsker, J. M., Hansen, A. M. & Caspi, R. R. Th1 and Th17 cells: adversaries and collaborators. Ann. NY Acad. Sci. 1183, 211-221 (2010).
18. Littman, D. R. & Rudensky, A. Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845-858 (2010).
19. Roark, C. L., Simonian, P. L., Fontenot, A. P., Born, W. K. & O'Brien, R. L. Gammadelta T cells: an important source of IL-17. Curr. Opin. Immunol. 20, 353-357 (2008).
20. Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647-675 (2012).
21. Almeida, A. R. M., Zaragoza, B. & Antonio, A. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+regulatory t cells is indexed to the number of IL-2-producing cells. J. Immunol. 177, 192-200 (2006).
22. Goldstein, J. D. et al. Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function. Front. Immunol. 4, 155 (2013).
23. Wan, Y. Y. & Flavell, R. a Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl Acad. Sci. USA 102, 5126-5131 (2005).
24. Lochner, M. et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 205, 1381-1393 (2008).
25. Neurath, M. F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14, 329-342 (2014).
26. Almeida, A. R. M., Zaragoza, B. & Freitas, A. A. Indexation as a novel mechanism of lymphocyte homeostasis: The number of CD4+CD25+ regulatory t cells is indexed to the number of IL-2-producing cells. J. Immunol. 177, 192-200 (2006).
27. Muranski, P. & Restifo, N. P. Essentials of Th17 cell commitment and plasticity. Blood 121, 2402-2414 (2013).
28. Passerini, L. et al. STAT5-signalling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25-effector T cells. Int. Immunol. 20, 421-431 (2008).
29. Collins, A., Littman, D. R. & Taniuchi, I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat. Rev. Immunol. 9, 106-115 (2009).
30. Adamson, A. S., Collins, K., Laurence, A. & O'Shea, J. J. The Current STATus of lymphocyte signalling: new roles for old players. Curr. Opin. Immunol. 21, 161-166 (2009).
31. Burchill, M. a, Yang, J., Vogtenhuber, C., Blazar, B. R. & Farrar, M. A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280-290 (2007).
32. Ostanin, D. V et al. T-cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G135-G146 (2009).
33. Blatner, N. R. et al. Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci. Transl. Med. 4, 164ra159 (2012).
34. Zhang, F., Meng, G. & Strober, W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9, 1297-1306 (2008).
35. Imamichi, H., Sereti, I. & Lane, H. C. IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3. Eur. J. Immunol. 38, 1621-1630 (2008).
36. Xu, L., Kitani, A., Fuss, I. & Strober, W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178, 6725-6729 (2007).
37. Akdis, M. et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 127, 701-721 (2011).
38. Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967-974 (2007).
39. Eri, R., McGuckin, M. A. & Wadley, R. T-cell transfer model of colitis: a great tool to assess the contribution of T cells in chronic intestinal inflammation. Methods Mol. Biol. 844, 261-275 (2012).
40. Vainer, B., Nielsen, O. H., Hendel, J., Horn, T. & Kirman, I. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine 12, 1531-1536 (2000).
41. Weigmann, B. et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2, 2307-2311 (2007).
42. Fitch, F. W., Gajewski, T. F. & Hu-Li, J. Production of TH1 and TH2 cell lines and clones. Curr. Protoc. Immunol Chapter 3, Unit 3.13 (2006).
43. Fantini, M. C., Dominitzki, S., Rizzo, A., Neurath, M. F. & Becker, C. In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells. Nat. Protoc. 2, 1789-1794 (2007).